Announced Thu, 24 Sept, 2026 · 21:36 IST
RPG Life Sciences completes Actis Generics acquisition
RPGLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.0%1-day move
₹2935.50
prior close
₹2878.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+0.3+0.6+0.6+2.0+5.7+3.6+0.5-1.0-1.4————
Up moveDown movePending
AI summary
RPG Life Sciences, through its wholly-owned subsidiary RPG Active Pharma Limited, has completed the acquisition of Actis Generics Private Limited as of September 24, 2026. Actis has now become a step-down subsidiary of RPG Life Sciences. The deal was originally signed via a Share Purchase Agreement dated July 29, 2026.
Likely market impact
Actis Generics is now part of the RPG Life Sciences group as a subsidiary, expanding the company's business footprint. May support future revenue growth.